Pilulka Lekarny as (PR:PINK) — Market Cap & Net Worth
Market Cap & Net Worth: Pilulka Lekarny as (PINK)
Pilulka Lekarny as (PR:PINK) has a market capitalization of $15.12 Million (Kč315.33 Million) as of September 16, 2026. Listed on the PR stock exchange, this Czech Republic-based company holds position #26050 globally and #18 in its home market, demonstrating a -0.43% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Pilulka Lekarny as's stock price Kč116.50 by its total outstanding shares 2706678 (2.71 Million). Also see Pilulka Lekarny as (PINK) total assets for a full breakdown of the balance sheet.
Pilulka Lekarny as Market Cap History: 2020 to 2026
Pilulka Lekarny as's market capitalization history from 2020 to 2026. Data shows change from $75.95 Million to $15.12 Million (-21.91% CAGR). Also see cash efficiency ratio of Pilulka Lekarny as for how efficiently the company converts equity into cash flow.
Pilulka Lekarny as Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Pilulka Lekarny as's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Check Pilulka Lekarny as stock quote for real-time trading data and today's change.
Latest Price to Sales (P/S) Ratio
0.01x
Pilulka Lekarny as's market cap is 0.01 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2020 | $75.95 Million | $1.78 Billion | -$25.64 Million | 0.04x | N/A |
| 2021 | $218.75 Million | $2.38 Billion | -$25.67 Million | 0.09x | N/A |
| 2022 | $84.38 Million | $2.45 Billion | -$65.76 Million | 0.03x | N/A |
| 2023 | $31.94 Million | $2.13 Billion | -$174.94 Million | 0.01x | N/A |
| 2024 | $13.96 Million | $1.30 Billion | -$125.74 Million | 0.01x | N/A |
Competitor Companies of PINK by Market Capitalization
Companies near Pilulka Lekarny as in the global market cap rankings as of September 16, 2026. Review Pilulka Lekarny as (PINK) tangible net worth to assess the quality of the company's equity after excluding intangible assets.
Key companies related to Pilulka Lekarny as by market ranking:
- JD HEALTH INTL LTD (F:8ZN): Ranked #1929 globally with a market cap of $12.04 Billion USD ( €10.30 Billion EUR).
- Walgreens Boots Alliance Inc (NASDAQ:WBA): Ranked #2172 globally with a market cap of $10.37 Billion USD.
- ALIB.HL.INF.TEC.UNSP.ADR (F:TWYA): Ranked #2541 globally with a market cap of $8.42 Billion USD ( €7.20 Billion EUR).
- Raia Drogasil S.A (SA:RADL3): Ranked #2963 globally with a market cap of $6.67 Billion USD ( R$34.01 Billion BRL).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #1929 | JD HEALTH INTL LTD | F:8ZN | $12.04 Billion | €3.80 |
| #2172 | Walgreens Boots Alliance Inc | NASDAQ:WBA | $10.37 Billion | $11.98 |
| #2541 | ALIB.HL.INF.TEC.UNSP.ADR | F:TWYA | $8.42 Billion | €8.95 |
| #2963 | Raia Drogasil S.A | SA:RADL3 | $6.67 Billion | R$19.45 |
Pilulka Lekarny as Historical Marketcap From 2020 to 2026
Between 2020 and today, Pilulka Lekarny as's market cap moved from $75.95 Million to $ 15.12 Million, with a yearly change of -21.91%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | Kč15.12 Million | -31.47% |
| 2025 | Kč22.07 Million | +58.14% |
| 2024 | Kč13.96 Million | -56.30% |
| 2023 | Kč31.94 Million | -62.15% |
| 2022 | Kč84.38 Million | -61.42% |
| 2021 | Kč218.75 Million | +188.03% |
| 2020 | Kč75.95 Million | -- |
End of Day Market Cap According to Different Sources
On Sep 16th, 2026 the market cap of Pilulka Lekarny as was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $15.12 Million USD |
| MoneyControl | $15.12 Million USD |
| MarketWatch | $15.12 Million USD |
| marketcap.company | $15.12 Million USD |
| Reuters | $15.12 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Pilulka Lekarny as
Pilulka Lékárny a.s. operates a network of pharmacy stores under the Pilulka brand in the Czech Republic, Slovakia, Romania, Hungary, and Austria. The company distributes medicinal products; online sale of pharmacy and related goods for health; and healthy lifestyle and services under the Pilulka brand. It also operates Internet portals, such as Pilulka.cz, Pilulka.sk, Pilulka.ro, Pilulka.hu, and… Read more